Ruxolitinib in Operable Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
AVID100 in Advanced Epithelial Carcinomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Immune Response Evaluation to Curative Conventional Therapy
- Status
- UNKNOWN
- Phase
- N/A
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).
- Status
- COMPLETED
- Phase
- PHASE1
Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC
- Status
- COMPLETED
- Phase
- NA
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab in HNSCC With Residual Disease After Radiation
- Status
- TERMINATED
- Phase
- PHASE2
Anti-tumor Specific Immune Response in Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- N/A
Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2